Drug Search Results

Hemoglobin glutamer

Alternative Names: hemoglobin glutamer
Latest Update: 2024-12-20
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Oxygen Binder

Novel Mechanism: Yes

Modality: Large Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Peru | Russia

Approved Indications: None

Known Adverse Events: None

Company: Biopure
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Peripheral Arterial Disease|Peripheral Vascular Diseases|Coronary Artery Disease|Myocardial Ischemia

Trial	Phase	Trial Status	Disease	Primary Completion Date
2005-003639-30	P2	Completed	Unknown	2009-07-16
Registry Study	P2	Unknown status	Myocardial Ischemia\|Coronary Artery Disease	2008-07-01
BIOSA001/BIOEU001	P2	Terminated	Peripheral Vascular Diseases\|Peripheral Arterial Disease	2008-06-01

Recent News Events

Date	Type	Title
06/03/2019	News Article	Hemoglobin Oxygen Therapeutics LLC Announces Multiple Presentations Using Hemopure® in Donor Livers Previously Rejected for Transplant.
06/03/2019	News Article	Hemoglobin Oxygen Therapeutics LLC Announces Multiple Presentations Using Hemopure® in Donor Livers Previously Rejected for Transplant.
04/18/2019	News Article	Hemopure Plays A Pivotal Role In A Pioneering Study Published in Nature
04/09/2019	News Article	Hemoglobin Oxygen Therapeutics LLC Announces Preclinical Results on Hemopure in Kidneys Discarded for Human Transplantation

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions